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The transcription factor Erm is a member of the Pea3 subfamily of Ets domain proteins that is expressed in multipotent
neural crest cells, peripheral neurons, and satellite glia. A specific role of Erm during development has not yet been
established. We addressed the function of Erm in neural crest development by forced expression of a dominant-negative form
of Erm. Functional inhibition of Erm in neural crest cells interfered with neuronal fate decision, while progenitor survival
and proliferation were not affected. In contrast, blocking Erm function in neural crest stem cells did not influence their
ability to adopt a glial fate, independent of the glia-inducing signal. Furthermore, glial survival and differentiation were
normal. However, the proliferation rate was drastically diminished in glial cells, suggesting a glia-specific role of Erm in
controlling cell cycle progression. Thus, in contrast to other members of the Pea3 subfamily that are involved in late steps
of neurogenesis, Erm appears to be required in early neural crest development. Moreover, our data point to multiple,
lineage-specific roles of Erm in neural crest stem cells and their derivatives, suggesting that Erm function is dependent on
the cell intrinsic and extrinsic context. © 2002 Elsevier Science (USA)
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The family of Ets domain transcription factors consists of
transcriptional activators and repressors that are character-
ized by a conserved DNA-binding Ets domain (Sharrocks,
2001). The activity of Ets proteins is modulated by phos-
phorylation events and by their interaction with other
coregulatory proteins, which allows Ets domain transcrip-
tion factors to act as nuclear effectors of multiple signal
transduction pathways (Wasylyk et al., 1998). Ets proteins
have been found in various organisms and cell types and are
thought to be involved in various biological processes. In
hematopoietic lineages, proliferation, survival, cell-type
specification, and differentiation all involve control by Ets
domain proteins (Remy and Baltzinger, 2000; Sharrocks,
2001). Thereby, a given Ets domain transcription factor can
elicit distinct functions presumably dependent on the part-
ner proteins it interacts with (DeKoter and Singh, 2000;
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168DeKoter et al., 1998). In the nervous system, spinal circuits
are marked by the coordinate expression of specific Ets
proteins in motor and sensory neurons that contact the
same peripheral muscle target (Lin et al., 1998). The Ets
factors involved are Pea3 and ER81, both members of the
Pea3 subfamily, that are expressed in neurons upon target-
derived signaling. Targeted deletion of Er81 results in the
loss of motor coordination due to reduced connections
between a subgroup of sensory afferents and the correspond-
ing motor neurons (Arber et al., 2000). Thus, Er81 controls
a late step in sensory-motor circuit formation. In contrast,
mice carrying a Pea3 mutation are phenotypically normal
but display male sexual dysfunction, possibly due to an
underlying neuronal abnormality (Laing et al., 2000). Func-
tional compensation between Ets factors might prevent
more severe phenotypes in these mutants.
In addition to Pea3 and ER81, the transcription factor
Erm also belongs to the Pea3 subfamily of Ets proteins
(Monte´ et al., 1994). Erm is expressed in several areas of the
nervous system, but, unlike Pea3 and ER81, is absent in
motor neurons of the spinal cord (Chotteau-Lelie`vre et al.,
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1997; Hagedorn et al., 2000; Lin et al., 1998). While Erm is
not detectable in emigrating neural crest cells, its expres-
sion is induced at early stages in aggregating peripheral
ganglia. In peripheral ganglia, Erm expression is found in
multipotent progenitors, neurons, and satellite glia,
whereas Schwann cells are devoid of Erm expression (Hage-
dorn et al., 2000). Both in cultured neural crest stem cells
(NCSCs) and in multipotent progenitor cells isolated from
dorsal root ganglia (DRG), Erm expression is regulated by
NRG1 signaling (Hagedorn et al., 2000). In such cultures,
NRG1 instructs multipotent neural crest cells to adopt a
glial fate (Hagedorn et al., 1999; Shah et al., 1994). In
addition, NRG1 is a survival factor for a subpopulation of
DRG-derived multipotent progenitor cells (Paratore et al.,
2001). The regulation of Erm by NRG1 raises the question
of whether Erm might regulate glial fate acquisition and
survival of multipotent neural crest cells, similar to the
function of the transcription factor Sox10 in neural crest
development (Paratore et al., 2001). Alternatively, Erm
might control other processes, such as survival, prolifera-
tion, or differentiation of peripheral glia, given its continu-
ous expression in satellite glia (Hagedorn et al., 2000). In
contrast to its expression in satellite glia, Erm expression in
peripheral neurons is independent of NRG1 signaling. It
remains to be determined whether, in neurons, Erm plays a
role similar to ER81 and Pea3 in establishing neuronal
connections, or whether it is involved already at earlier
stages of neurogenesis.
The goal of the present study was to elucidate the
developmental processes regulated by Erm in the peripheral
nervous system (PNS). Mice carrying a targeted deletion of
Erm are lethal at early embryonic stages (S. Arber and J.
Hassell, personal communication), precluding an analysis
of Erm function in neural development in these mutants.
Therefore, we used forced expression of a dominant-
negative form of Erm to block its function in NCSCs. The
data presented in this study suggest multiple roles of Erm in
neural crest development.
MATERIALS AND METHODS
Plasmids
EnR-Erm was constructed by fusing the engrailed repressor (EnR)
domain sequence (a gift from A. Braendli, ETH Zurich, and R.
Rupp, University of Munich) to the 5 end of the sequence encoding
the DNA-binding domain of Erm. The Erm Ets domain was PCR
amplified from pSV-Erm (Defossez et al., 1997), introducing a stop
codon at the 3 end. This fragment was cloned together with EnR
into pSE280 (Invitrogen) to generate pSE280-EnR-Erm. NLS-MT-
EnR-Erm was subcloned into pBabe-EGFP (a gift from B. Amati,
DNAX Research Institute, Palo Alto, CA), resulting in the retrovi-
ral construct EnR-Erm containing also the reporter gene EGFP.
pSV-Erm and 3xTORU Luc were both gifts from J.-L. Baert and Y.
de Launoit (Institut de Pasteur de Lille) and have been described in
Defossez et al. (1997).
Transfection Assays
HEK cells were maintained in DMEM supplemented with 10%
fetal bovine serum. Subconfluent cells were transfected in six-well
plates with SuperFect (Qiagen) according to the manufacturer’s
instructions. Each dish was transfected with 0.1 g CMV-lacZ, 0.3
g 3xTORU Luc, 0.25 g pSV-Erm, and 2.75 g EnR-Erm or 2.75 g
pBabe-EGFP. Forty-eight hours post-transfection, the cells were
harvested and the luciferase activity measured by using LucLite
Plus (Packard). To normalize for transfection efficiency, a CMV-
LacZ plasmid was cotransfected and the -galactosidase activity
was determined by using the Tropix Galacto-Star Kit according to
the manufacturer’s instructions (Perkin Elmer).
Cell Cultures and Retroviral Infection
Time-mated OFA rats were obtained from RCC Ltd. (Fu¨llinsdorf,
Switzerland). Neural crest cultures were performed from embry-
onic day (E) 10.5 embryos as previously reported (Hagedorn et al.,
1999; Stemple and Anderson, 1992). One day after plating the
neural tubes, the emigrated cells were replated onto 0.25-mg/ml
fibronectin (FN) (Roche Diagnostics)-coated dishes. Fourteen hours
later, the cells were infected with control- or EnR-Erm-expressing
retroviral supernatants. After 2.5 h of incubation, the medium was
changed to standard medium (Stemple and Anderson, 1992) and the
cells were allowed to recover for 30 min. This infection procedure
was repeated twice (Lo et al., 1997). After the last recovery step, the
cells were replated clonally onto 35-mm culture dishes (Corning)
coated with 0.5 mg/ml poly-D-lysine (Roche Diagnostics) and FN
and cultured in standard medium. Another 18 h later, when
transgene expression has taken place, infected and EGFP-positive
single cells were mapped by inscribing a circle on the bottom of the
cell culture dish. In some experiments, the standard medium was
supplemented with either 1 nM rhGGF2, a soluble NRG1 isoform
(a gift from M. Marchionni, Cambridge NeuroScience), 1.6 nM
BMP2 (a gift from Genetics Institute, Cambridge, MA), or Delta-Fc
(a gift from G. Weinmaster, University of California Los Angeles) at
the time point of labeling. Production and concentration of
Delta-Fc was as described in Morrison et al. (2000). The prolifera-
tion assay of differentiating glia was as follows: after emigration,
neural crest cells were treated with 1 nM rhGGF2 for 1.5 days.
Then, the neural tube was removed and the cells were replated at
high density and incubated for another 2 days in the presence of
rhGGF2. Subsequently, the glial cells derived from neural crest
cells were infected, replated at clonal density, and labeled as
described above. After another 5.5 days of culture in the presence of
rhGGF2, the cells were fixed and analyzed.
Immunocytochemistry
The cells were fixed with 3.7% formaldehyde in PBS for 10 min.
Progenitor cells were labeled with rabbit anti-mouse p75 (Chemi-
con International) diluted 1:200 in blocking buffer containing 10%
goat serum, 0.1% BSA in PBS for 1 h at RT and visualized by
Cy3-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories). The following stainings were performed for 2 h at RT
in blocking buffer containing 0.3% Triton X-100: monoclonal
Sox10 antibody (1:3 dilution; Paratore et al., 2001), mouse mono-
clonal anti-human c-Myc antibody (9E10; 1:3 dilution; Develop-
mental Studies Hybridoma Bank), rabbit anti-NF160 (1:200 dilu-
tion; Chemicon International), rabbit anti-cow S100 (1:200
dilution, Dako), monoclonal anti-NF160 antibody NN18 (IgG), and
monoclonal anti-smooth muscle actin (IgG) (1:400 dilution; Sigma).
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After primary antibody incubation, the labeling was visualized by
incubation for 1 h at RT with FITC-conjugated secondary antibod-
ies (anti-mouse antibody, Vector Laboratories; anti-rabbit antibody,
Jackson ImmunoResearch Laboratories) or Cy3-conjugated second-
ary antibodies (anti-mouse and anti-rabbit antibody, Jackson Im-
munoResearch Laboratories). Rabbit polyclonal anti-Erm antibody
(Janknecht et al., 1996) was affinity purified by using Reacti-Gel
HW-65 according to the manufacturer’s instructions (Pierce), as
described in Hagedorn et al. (2000). Erm labeling (antibody dilution
1:200) was performed for 2 h at RT, followed by incubation with
biotin-SP-conjugated donkey anti-rabbit IgG antibody (Jackson
ImmunoResearch Laboratories). Staining was visualized by the
ABComplex Kit (DAKO) with horseradish peroxidase development
using diaminobenzidine as substrate.
RESULTS
Neural Expression of Erm in Cultured Neural
Crest Cells
In situ hybridization experiments revealed expression of
the Ets domain transcription factor Erm in neural cells of
dorsal root ganglia (DRG), cranial sensory ganglia, and
sympathetic ganglia (Chotteau-Lelie`vre et al., 1997; Hage-
dorn et al., 2000). Moreover, multipotent neural crest cells
from neural crest explants and from DRG, satellite glia
derived from these cells, and sensory neurons have been
shown to be Erm-immunoreactive (Hagedorn et al., 2000).
In order to further elucidate the expression pattern of Erm
protein, neural crest stem cells (NCSCs) derived from rat
neural crest explants were allowed to differentiate into
satellite glia in the presence of NRG1, neurons in the
presence of BMP2, and smooth muscle-like cells in the
presence of TGF. In agreement with our previous report
(Hagedorn et al., 2000), virtually all undifferentiated p75-
positive NCSCs and satellite glia expressing glial fibrillary
acidic protein (GFAP) derived from NCSCs were positive
for Erm (Figs. 1A–1F). Likewise, Erm was expressed in
neurofilament 160 (NF)-positive neurons generated de novo
in cultures of neural crest cells (Figs. 1G–1I). In contrast,
smooth muscle actin (SMA)-positive non-neural cells de-
rived from NCSCs were negative for Erm expression (Figs.
1J–1L). Thus, the progression of NCSCs to neurons and glia
is marked by the continued expression of the Ets domain
transcription factor Erm.
Forced Expression of a Dominant-Negative Form of
Erm in Neural Crest Cells
Erm has been shown to be a transcriptional activator
(Laget et al., 1996). To address whether Erm plays a role in
regulating processes of neuronal and glial development, we
designed a dominant-negative form of Erm that would act
as a transcriptional repressor and should therefore interfere
with Erm function in NCSCs. This form, called EnR-Erm,
consisted of the DNA-binding domain of Erm that was
tagged by a nuclear localization signal and a c-Myc epitope
(NLS-MT) and fused to the engrailed repressor (EnR) (Han
and Manley, 1993) (Fig. 2A). EnR-Erm expression was
driven from the LTR of a retroviral expression vector.
Concomitant expression of EGFP from an internal CMV
promoter allowed to monitor living cells upon infection of
the retroviral vector. A control vector encoded EGFP but no
Erm fusion protein (Fig. 2A). Immunostaining of infected
NCSCs with an anti-Myc antibody confirmed the nuclear
expression of EnR-Erm, concomitant with expression of
EGFP (Fig. 2B). A very similar approach involving a
dominant-negative form of Pea3 fused to the engrailed
repressor was recently used successfully by Hassell and
colleagues to inhibit Pea3 function in mammary tumori-
genesis (Shepherd et al., 2001). Such inhibitory fusion
constructs are thought to act by competing for binding sites
in promoters of target genes. The inhibitory activity of
EnR-Erm on the transactivation potential of Erm was con-
firmed in a transient transfection assay performed in HEK
cells. Previously, full size Erm has been shown to transac-
tivate a reporter gene containing an artificial promoter with
three Ets binding sites (Defossez et al., 1997). Cotransfec-
tion of full size Erm and this reporter construct together
with a 10-fold molar excess of the EnR-Erm construct
reduced the transactivation capacity of Erm to approxi-
mately 20% of that displayed by Erm alone, as measured by
a luciferase assay (Fig. 2C).
In another experiment, forced expression of EnR-Erm in
neural crest cells was performed to investigate whether
repression of Erm activity would have an effect on neural
crest development. To this end, neural crest cells from rat
neural crest explants were replated and infected either with
virus encoding EnR-Erm or with control virus (see Materi-
als and Methods). Subsequently, the cells were replated at
clonal density and the position of individual infected cells
was mapped. Infected neural crest cells were identified by
virtue of EGFP expression from the retroviral vectors. The
cultures were then incubated in standard medium that
allows differentiation of multipotent neural crest cells into
neurons, glia, and non-neural smooth muscle-like cells
(Hagedorn et al., 1999; Stemple and Anderson, 1992). After
8 days of incubation, the clonal cultures were fixed. The
cellular composition of the clones was analyzed by immu-
nostaining for Sox10 to label presumptive glia (Paratore et
al., 2001) and for NF to mark neuronal cells. Non-neural
cells were identified by the absence of both of these mark-
ers. Upon infection of EnR-Erm virus, neural crest cells
generated slightly decreased numbers of mixed clones, i.e.,
clones that contained more than one cell type, as compared
with control-infected neural crest cells (29 and 38% of all
colonies, respectively) (Fig. 3). Should Erm have multiple
influences on number and type of cells produced in mixed
clones, the cellular role of Erm in NCSCs and their deriva-
tives might be difficult to address by the analysis of such
colonies. However, in addition to mixed colonies, many
infected clones were restricted to a single cell type.
Thereby, the fates chosen by restricted neural crest cells
were significantly altered upon forced expression of EnR-
Erm. In control cultures, 16% of all colonies contained
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exclusively Sox10-positive presumptive glia, 10% only neu-
rons, and 15% were composed solely of smooth muscle-like
cells (Fig. 3). In contrast, the vast majority of EnR-Erm-
expressing cells gave rise to glia-only clones (35% of all
colonies) and 15% of all colonies contained only smooth
muscle-like cells (Fig. 3). Strikingly, only 1% of all colonies
were neuron-exclusive clones in cultures infected with
EnR-Erm virus, indicating that the dominant-negative form
of Erm impaired the generation of clones restricted to a
neuronal lineage. Since cell death of founder neural crest
cells was not increased in EnR-Erm-infected cultures as
compared with control cultures, the low frequency of
neuron-restricted clones in cultures expressing EnR-Erm
was not simply due to selective elimination. Rather, the
loss of purely neuronal clones and the concomitant increase
of glia-only colonies suggests an instructive role of
dominant-negative Erm in biasing fate decisions of NCSCs.
In addition to altered cell type composition in EnR-Erm-
expressing colonies, we found that the clone size of glia-
restricted colonies was affected. In particular, the majority
of neural crest cells that gave rise to glia-restricted colonies
in control cultures proliferated considerably, so that very
few control-infected clones comprised less than four cells
(11% in a first experiment, 0% in a second experiment;
FIG. 1. Expression of Erm in neural crest cells and derivatives. Neural crest stem cells (NCSCs) replated from neural crest explants were
fixed after 4 h and immunolabeled using anti-Erm antibody (visualized by a biotin/avidin-amplified HRP reaction) (A) and anti-p75 antibody
(visualized by Cy3 fluorescence) (B). Sister cultures of replated NCSCs were allowed to develop in the presence of NRG1. In these cultures,
Erm expression (D) was maintained in differentiated glia that are positive for GFAP (visualized by Cy3 fluorescence) (E). In BMP2-treated
cultures, crest cells differentiated into neurofilament (NF)-positive neurons (visualized by FITC fluorescence) (H), while TGF-treated
cultures gave rise to smooth muscle actin (SMA)-expressing non-neural cells (K). The latter did not express Erm (J) whereas neurons
maintained Erm expression (G). (C, F, I, L) The corresponding phase pictures.
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Table 1). In contrast, upon forced expression of dominant-
negative Erm, 80–100% of all glia-only clones contained
less than four cells (Table 1). Loss of founder cells and of
cells within clones was not increased upon EnR-Erm infec-
tion. These data indicate a markedly decreased proliferation
rate in EnR-Erm-infected in cells of the glial lineage. Neu-
ronal and non-neural clone types, however, were of compa-
rable size in EnR-Erm-infected and in control cultures (data
not shown).
Dominant-Negative Erm Impairs Neuronal Fate
Decision in Neural Crest Cells
The abovementioned experiments were performed with
neural crest cells incubated in standard medium that is
permissive for the formation of neurons, glia, and non-
neural smooth muscle-like cells. Our results obtained by
forced expression of dominant-negative Erm in such cul-
tures were consistent with differential roles of Erm in fate
decision and proliferation. Thus, in mixed clones contain-
ing several cell types, opposing and overlapping effects
might influence the number of a given cell type, which
makes these clones difficult to analyze. Therefore, to better
distinguish the effects of functional inhibition of Erm in
different neural crest lineages, EnR-Erm-expression assays
were carried out in neural crest cells promoted to generate
FIG. 3. Clonal analysis of neural crest cells expressing dominant-
negative Erm. Neural crest cells were infected with either control
or EnR-Erm virus, and single EGFP-positive cells were mapped and
allowed to differentiate in standard conditions permissive for
neural and non-neural fates. After differentiation for 8 days, the
cellular composition of the clones was analyzed. For the quantita-
tive analysis, expression of Sox10, NF160, and absence of these
markers were used to distinguish between different fates. When
compared with control infected clones, EnR-Erm-infected clones
showed a strongly reduced number of clones consisting solely of
neurons (N-clones). In contrast, the number of clones that con-
sisted of presumptive glia only (G-clones) was increased. “S”
indicates the number of clones containing exclusively non-neural
smooth muscle-like cells, “Mixed” the number of clones contain-
ing more than one cell type, and “Death” indicates loss of clones.
The numbers are given as the mean  SD of three independent
experiments. In each experiment, 50 clones were analyzed. Signifi-
cant differences between Control and Erm-EnR infected cultures
are marked by an asterisk (P  0.0005, Student’s t test).
FIG. 2. Construction and analysis of a retroviral vector expressing a
dominant-negative form of Erm. (A) Schematic structure of full-length
Erm, retroviral EnR-Erm vector, and control vector. Erm encompasses
two activation domains (AD1, AD2) and a DNA-binding Ets domain
(Ets). To construct dominant-negative Erm, its Ets domain was fused
to the engrailed repressor (EnR). EnR possesses a nuclear localization
sequence (NLS) and a Myc epitope tag (MT) at its N terminus. This
repressor construct was subcloned into a retroviral expression vector
encoding an EGFP reporter gene. EGFP expression is driven from a
CMV promoter. The EGFP-expressing vector without EnR-Erm
served as control vector. (B) Test infections performed on neural crest
cells demonstrated transport of the fusion protein into the nucleus
(visualized by DAPI-labeling), as assessed by anti-Myc staining. In-
fected cells were also marked by EGFP reporter gene expression. (C)
The repressor activity of EnR-Erm was analyzed in a luciferase
transactivation assay. Two independent experiments were performed
(Exp. 1 and Exp. 2). The reporter construct 3xTORU Luc that contains
several Ets binding sites was transfected either alone, together with
pSV-Erm encoding full-length Erm (Erm), or together with pSV-Erm
and EnR-Erm. The luciferase activity measured upon transactivation
of the reporter construct by pSV-Erm alone was set to 100%, while the
baseline represents the activity of the reporter construct alone.
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specific lineages. To this end, neural crest cells were in-
fected with control virus or virus encoding EnR-Erm and
replated at clonal density as described above. In a first set of
experiments, the cultures were thereafter treated with
BMP2 that stimulates neurogenesis and, to a lesser extent,
the generation of smooth muscle-like cells in NCSCs (Shah
et al., 1996). Mapping of EGFP-expressing cells allowed us
to determine the progeny of individual infected founders.
Typically, control-infected clones treated with BMP2 con-
tained NF-positive neurons, and many of these clones
consisted exclusively of neurons (Figs. 4A, 4C, and 4E). In
contrast, the majority of clones expressing dominant-
negative Erm did not adopt a neuronal fate and were
composed of SMA-positive non-neural cells (Figs. 4B, 4D,
and 4F). Quantification of these experiments revealed that
in control cultures, 34% of all colonies consisted of neurons
only, 29% were mixed containing neurons and smooth
muscle-like cells, and 25% were composed of smooth
muscle-like cells only (Fig. 4G). In these conditions, 12% of
all colonies were lost due to cell death. Inhibition of Erm
activity in BMP2-treated NCSCs reduced the number of
neuron-containing clones, with only 17% of all colonies
consisting exclusively of neurons and 15% containing neu-
rons and smooth muscle-like cells (Fig. 4G). Instead, 56% of
all neural crest founder cells overexpressing EnR-Erm gave
rise to clones that were composed solely of smooth muscle-
like cells. Similar to control cultures, only 12% of all
mapped cells expressing EnR-Erm underwent cell death.
Thus, as in cultures incubated in standard medium (Fig. 3),
blocking Erm function affected neurogenesis in BMP2-
treated NCSCs. In the presence of BMP2, this led to the
formation of non-neural cells at the expense of neurons,
demonstrating a fate switch of NCSCs. Cell cycle progres-
sion in neuronal clones was not affected, however, since the
neuronal clones generated despite the expression of EnR-
Erm consisted of similar cell numbers as control-infected
neuronal clones (Table 2).
Blocking Erm Function in Neural Crest Cells
Decreases the Proliferation Rate in the Peripheral
Glial Lineage without Affecting
Glial Fate Decision
To assess the role of dominant-negative Erm in peripheral
glia development, the infection experiments described
above were repeated and the infected neural crest cells in
clonal cultures were exposed to glia-inducing signals.
NRG1 instructs multipotent neural crest cells to adopt a
glial fate (Hagedorn et al., 1999; Shah et al., 1994). p75-
positive neural crest cells infected by control virus exten-
sively proliferated in the presence of NRG1 and within 6
days of incubation formed clones expressing Sox10 (not
shown) as well as the glial differentiation marker S100 (Figs.
5A–5F). Forced expression of EnR-Erm did not impair glial
differentiation of neural crest cells, and infected cells were
able to upregulate S100 expression similar to cells in
control cultures (Figs. 5G–5L). However, EnR-Erm-infected
cells hardly proliferated, often forming clones of only one or
two cells (Figs. 5H, 5J, and 5L). To quantify this phenom-
enon, infected glial clones obtained after 6 days of NRG1
treatment were classified according to the cell number per
clone. In control cultures, 29% of all glial clones comprised
more than 20 cells, 53% were composed of 10–20 cells, and
only 18% of the colonies had less than 10 cells per clone
(Fig. 6). In contrast, clones with more than 20 cells were rare
(4% of all glial clones) and only 27% of the colonies were in
the category of 10–20 cells upon EnR-Erm infection.
Rather, most of the EnR-Erm-infected clones (69%) re-
mained small, containing less than 10 cells (Fig. 6). The
reduction of the clone size upon infection of dominant-
negative Erm was not simply due to increased cell death.
Loss of clones occurred at a similarly low frequency in
EnR-Erm infected and in control cultures (10 and 6%,
respectively). Moreover, daily observation of clones in cul-
ture did not reveal increased cell death within the infected
clones, excluding selective elimination of cells as an expla-
nation for the reduced clone size in EnR-Erm-infected
cultures (data not shown).
We have recently shown that Erm expression is regulated
by NRG1 in neural crest-derived cells (Hagedorn et al.,
2000). Therefore, the effect of dominant-negative Erm on
proliferation in NRG1-treated neural crest cells might be
dependent on signaling by NRG1. Alternatively, the effect
of dominant-negative Erm on proliferation might be
lineage-specific independently of the lineage-inducing
stimulus. In order to address this issue, gliogenesis in
infected cells was induced by exposure to a signal different
from NRG1. A soluble form of Delta (Delta-Fc) has previ-
ously been shown to promote gliogenesis from NCSCs
isolated from sciatic nerve and from neural crest explant
cultures (Morrison et al., 2000). Likewise, the majority of
neural crest cells that have been derived from rat neural
crest explants, submitted to three rounds of infection with
retrovirus, and replated at clonal density, adopted a glial
fate when exposed to soluble Delta (data not shown).
TABLE 1
Erm Is Required for Glial Proliferation
Exp. 1 Exp. 2
4 cells 4 cells 4 cells 4 cells
Control 11% 89% 0% 100%
EnR-Erm 100% 0% 80% 20%
Note. Neural crest cells were infected with control or EnR-Erm-
expressing virus and cultured in standard medium for 8 days.
Analysis of the number of cells within glia-only clones showed a
massive reduction of the cell number in EnR-Erm-infected clones.
In two independent experiments (Exp. 1 and Exp. 2), most of the
EnR-Erm-infected glial clones were smaller than 4 cells, while the
vast majority of control-infected glial clones consisted of more than
4 cells. Approximately 50 clones were analyzed per experiment. A
2 analysis revealed P values of less than 0.001 in both experiments.
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Thereby, promotion of gliogenesis by Notch activation was
independent from the retroviral construct used for infec-
tion, since forced expression of EnR-Erm did not alter the
frequency of glial clones generated in these cultures as
compared to control-infected cultures (data not shown). Of
the glial clones infected with control virus, 30% contained
more than 20 cells per clone, 50% had 10–20 cells per clone,
and merely 20% of all glial clones were smaller than 10
cells (Fig. 7). In contrast, similar to treatment with NRG1,
forced expression of dominant-negative Erm decreased the
size of glial clones in the presence of Delta. In particular,
only 5% of the EnR-Erm-expressing glial clones were bigger
than 20 cells and 16% consisted of 10–20 cells. Most clones
(73% of all glial colonies), however, remained smaller than
10 cells per clone (Fig. 7). Cell death of founder cells and
within developing clones was not affected by overexpres-
sion of EnR-Erm in Delta-treated cultures, as assayed by
daily observation of the cultures (data not shown). Thus,
the equivalent cell numbers found in glial clones treated
with NRG1 (Fig. 6) and with Delta (Fig. 7) demonstrate that
dominant-negative Erm decreased the proliferation rate in
developing peripheral glia independently of the glia-
inducing signal.
The above data indicate that glial fate acquisition and cell
cycle progression are independently regulated. Accordingly,
Erm might not only regulate proliferation in neural crest
cells exposed to glia-promoting cues but also in glial cells
that have already adopted their specific fate. In order to test
this hypothesis, we treated neural crest cells with NRG1 for
several days, which promotes gliogenesis and maintains
endogenous Erm expression in glial cells (Hagedorn et al.,
2000; Shah et al., 1994). Thereafter, infection with control
retrovirus or with the EnR-Erm-expressing virus was per-
formed and proliferation of infected glia was assayed as
described before. Similar to the results obtained with neural
crest cells cultured in gliogenic conditions, dominant-
negative Erm also reduced the proliferation rate of differen-
tiating glia (Table 3). In particular, in two independent
experiments, the number of glial clones containing more
than 10 cells was significantly decreased upon EnR-Erm
infection, while the number of clones with fewer than 10
glia increased as compared with control-infected cultures
(Table 3). Thus, the role of Erm in regulating glial prolifera-
tion is independent of the process of glial fate decision.
muscle-like cells (N/S-clones) was reduced, while that of smooth
muscle-only clones (S-clones) was increased. Note that no clones
consisting of multipotent cells or presumptive glia were found
under these conditions. Loss of clones was not affected upon
EnR-Erm infection. Numbers are shown as the mean  SD of three
independent experiments. Fifty clones were scored per experiment.
Student’s t test revealed a significant difference (P  0.05) compar-
ing control and Erm-EnR infected cultures (asterisks).
FIG. 4. Repression of Erm activity impairs neuronal fate decision
of neural crest cells in neurogenic conditions. Infected neural crest
cells plated at clonal density were grown in standard medium
supplemented with BMP2. The phenotype of clones derived from
previously marked neural crest cells was assessed by immunocy-
tochemistry 4 days after factor addition. Control-infected EGFP-
positive clones (A) often consisted of NF-positive neurons only (C).
EnR-Erm-infected clones (B) displayed a reduced neuronal capacity
and mostly adopted a non-neural fate marked by smooth muscle
actin (SMA) expression (D). (E, F) Phase contrast pictures. (G)
Quantitative clonal analysis of infected cells incubated in the
presence of BMP2 confirmed a bias of EnR-Erm infected cells to
give rise to non-neural cells. The number of neuron-only clones
(N-clones) and of clones containing both neurons and smooth
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DISCUSSION
In the vertebrate nervous system, members of the Pea3
subgroup of Ets domain transcription factors have been
implicated in establishing neuronal connections (Arber et
al., 2000; Lin et al., 1998). In the present study, we provide
evidence that the Pea3 factor Erm already plays a role at
earlier stages of neural development. Erm is expressed in
postmigratory multipotent neural crest cells, and its expres-
sion is maintained during neurogenesis and gliogenesis, but
downregulated when NCSCs adopt a non-neural fate (Hage-
dorn et al., 2000; this study). Loss-of-function experiments
using a dominant-negative form indicate differential roles
of Erm in neural crest development, depending on the cell
lineage to be generated (Fig. 8). Erm appears to interfere
with neuronal fate decision by NCSCs, while in neural
crest cells promoted to become glia, Erm regulates prolif-
eration without affecting glial fate acquisition. We cannot
exclude that Ets domain transcription factors other than
Erm are affected by overexpression of dominant-negative
Erm. However, no Ets domain transcription factor other
than Erm is known to be expressed in multipotent neural
crest cells as well as in neural lineages derived from them.
In particular, Pea3 and ER81, the Ets factors most closely
related to Erm, are in contrast to Erm not expressed in early
neural crest development but, in the PNS, are only found in
differentiated sensory neurons (Lin et al., 1998; Paratore et
al., 1999). Therefore, we assume that the observed effects in
neural crest cells expressing dominant-negative Erm are
specific for Erm and reveal its multiple lineage-specific
requirements.
Role of the Ets Domain Transcription Factor Erm
in Neuronal Fate Decision by Neural Crest
Stem Cells
Clonal cultures in which the fate of individual progenitor
cells can be followed upon genetic manipulation allow to
distinguish between roles of regulatory molecules in sur-
vival, proliferation, fate decision, or differentiation pro-
cesses (Anderson et al., 1997; Sommer, 2001). Forced ex-
pression of a dominant-negative form of Erm did neither
affect overall survival of neural crest cells in clonal cultures
nor did it prevent the expression of differentiation markers
in neuronal, glial and smooth muscle-like lineages. How-
ever, blocking Erm function decreased the frequency of
neuronal clones generated from NCSCs, leading to the
concomitant increase of non-neuronal clones. Thereby, the
type of non-neuronal clones preferentially generated was
dependent on the culture conditions chosen. In standard
FIG. 5. Dominant-negative Erm reduces the proliferation rate in
glial cells without affecting glial differentiation. Infected neural
crest cells plated at clonal density expressed EGFP and p75 at 1 day
(1d) after infection (A, C, G, I). Single infected neural crest cells
were mapped and grown in standard medium supplemented with
NRG1 for 6 days (6d). Glial differentiation as assayed by anti-S100
staining occurred both in control cultures (B, D) and in EnR-Erm-
infected cultures (H, J). However, the number of cells was reduced
within glial clones infected with EnR-Erm as compared to control-
infected clones. (E, F, K, L) phase contrast pictures.
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medium permissive for neurogenesis, gliogenesis as well as
the formation of smooth muscle-like cells, glial clones were
produced at the expense of neuronal clones; in the presence
of BMP2 that on single NCSCs induces neurogenesis and
the formation of non-neural cells but not glia (Shah et al.,
1996), non-neural clones were predominantly found in the
cultures. Moreover, the frequency of glial clones was not
affected by perturbing Erm function in glia-promoting con-
ditions, independent of whether NRG1 or Notch activation
was used as glia-instructive signal. These data suggest that,
although expressed in developing glia, Erm is specifically
required for efficient neuronal fate decision by NCSCs. Erm
appears not to be unique among Ets domain transcription
factors to regulate early developmental stages of a particular
cell lineage (Remy and Baltzinger, 2000; Sharrocks, 2001).
Overexpression experiments revealed a role of Pea3 in
myogenic differentiation (Taylor et al., 1997), while abla-
tion of the Pu.1 gene causes specific loss of lymphoid and
myeloid lineages (Scott et al., 1994). Similarly to Erm in
TABLE 2
Erm Is Not Required for Neuronal Proliferation
Exp. 1 Exp. 2
20 cells 10–20 cells 10 cells 20 cells 10–20 cells 10 cells
Control 22% 33% 45% 22% 30% 48%
EnR-Erm 31% 32% 37% 20% 40% 40%
Note. Dominant-negative Erm was overexpressed in neural crest cells incubated in the presence of BMP2. The number of neurons within
neuronal-only clones was analyzed in EnR-Erm- and control-infected cultures. The clones were classified into three categories according
to their size. In all categories, a 2 analysis of two independent experiments revealed no significant differences between the sizes of control-
and EnR-Erm-infected clones. The number of control- and EnR-Erm-infected clones analyzed was 63 and 57, respectively, in the first
experiment, and 64 and 65 in the second experiment.
FIG. 6. Quantitative analysis of the clone sizes obtained in
NRG1-treated cultures. Neural crest cells were infected and treated
as described in the legend to Fig. 5. Quantification of the number of
cells within glia-containing clones indicated that the amount of big
clones (20 cells) was reduced in EnR-Erm-infected cultures when
compared with control-infected, NRG1-treated cultures. In con-
trast, the number of small clones (10 cells per clone) was highly
increased upon EnR-Erm infection. The numbers are given as the
mean  SD of 3 independent experiments. In each experiment, 50
clones were analyzed (P  0.05, Student’s t test; asterisks). Note
that glial fate acquisition of NRG1-treated neural crest cells was
not affected by dominant-negative Erm (not shown).
FIG. 7. Reduced proliferation rate of EnR-Erm-infected glial cells
induced by Notch activation. Single infected EGFP-positive neural
crest cells were mapped and grown for 6 days in standard medium
supplemented with Delta-Fc (see Materials and Methods). Clonal
analysis revealed that EnR-Erm expression reduced the number of
cells per glial clone while glial fate decision by neural crest cells
was not affected (not shown). Unlike control-infected clones, few
EnR-Erm-infected clones consisted of more than 20 cells, while the
number of clones that were less than 10 cells was highly increased
upon inhibition of Erm function. The data are expressed as the
mean  SD of 3 independent experiments. In each experiment, 50
clones were scored. Asterisks indicate significant differences (P 
0.005, Student’s t test).
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neurogenesis, Pu.1 is not absolutely required for T cell
development, but plays a role in efficient specification of
progenitors to the T cell lineage (Spain et al., 1999).
Since Erm expression is maintained both in glial as well
as neuronal lineages derived from multipotent cells, Erm is
unlikely to act as a determinant of a neuronal fate on its
own. In agreement with this idea, forced expression of full
size Erm in neural crest cells cultured in the absence of
instructive growth factors yielded variable results with no
indication of Erm inducing neurogenesis (data not shown).
However, when neural crest cells in clonal cultures were
treated with BMP2, overexpression of full size Erm led to an
increase in the fraction of cells adopting a neuronal rather
than a non-neural fate (data not shown). Thus, it is conceiv-
able that Erm synergizes with another transcriptional regu-
lator to accomplish its function in neuronal development,
and BMP2 might induce expression of this co-factor. Modu-
lation of both DNA-binding and transcriptional activity by
protein-protein interactions is a characteristic property of
Ets factors (Li et al., 2000; Sharrocks, 2001; Wasylyk et al.,
1998). In particular, functional and physical interactions of
basic helix–loop–helix (bHLH) transcription factors with
Ets domain proteins have been observed. Several Ets factors
synergistically interact with ubiquitously expressed bHLH
proteins (Dang et al., 1998; Rivera et al., 1993). Members of
the ternary complex factor (TCF) subfamily of Ets proteins
associate with the bHLH factor E47, which increases DNA
binding (Maira et al., 1996), and with Id HLH factors, which
results in the dissociation of the transcription factor com-
plex (Yates et al., 1999). Moreover, cooperative interactions
of leucine zipper-containing bHLH proteins occurs with
Ets-1, Pu.1, and Pea3, and enhances DNA-binding and
transcriptional activation (Greenall et al., 2001; Sieweke et
al., 1998; Tian et al., 1999). Given the widely acknowledged
roles of bHLH factors in neural development (Anderson,
1999; Brunet and Ghysen, 1999; Lee, 1997) it will be
interesting to investigate whether Erm interacts and coop-
erates with bHLH proteins to regulate neuronal fate deci-
sions in the developing neural crest.
Lineage-Specific Regulation of Cell Cycle
Progression by Erm
In contrast to neuronal fate decision, glial fate acquisition
does not depend on Erm function since the frequency of
glial clones generated from NCSCs was not decreased by
expression of dominant-negative Erm. Furthermore, block-
ing Erm function did not affect the expression of glial
TABLE 3
Erm Regulates Cellular Proliferation in Glial Cells Independently of Glial Fate Acquisition
Exp. 1 Exp. 2
20 cells 10–20 cells 10 cells 20 cells 10–20 cells 10 cells
Control 19% 33% 48% 8% 29% 63%
EnR-Erm 8% 15% 77% 2% 8% 90%
Note. Neural crest cells were first treated for 3.5 days with NRG1 and, thereafter, infected with EnR-Erm and control virus. Single
infected cells were mapped and subsequently maintained in NRG1 for another 5.5 days. The cell number within individual control- and
EnR-Erm-infected glial clones was analyzed, scoring 58 and 61 clones, respectively, in the first experiment, and 51 and 59 clones in the
second experiment. In general, the clone sizes were reduced in EnR-Erm-infected as compared with control-infected clones. A 2 analysis
revealed a highly significant difference for both experiments. P  0.001.
FIG. 8. Differential roles of the Ets factor Erm in neural crest
cells. While early migratory neural crest cells do not express Erm,
its expression is upregulated in multipotent neural crest cells
aggregating in peripheral ganglia. Erm expression is maintained
both in neurons and satellite glia generated from these neural crest
cells (Hagedorn et al., 2000; this study). Loss-of-function (lof)
experiments reveal differential roles of Erm, depending on the cell
lineage. Erm is required for efficient neurogenesis by multipotent
neural crest cells, while it regulates proliferation without affecting
fate decision in neural crest cells promoted to become glia.
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differentiation markers in neural crest-derived glia. Never-
theless, our clonal culture experiments suggest a specific
role of Erm in the peripheral glial lineage. Clones expressing
dominant-negative Erm contained considerably less glial
cells than clones in control cultures. This was not due to
selective elimination of glial cells, since cell death was
neither increased in EnR-Erm-infected founder cells nor
within infected clones. Therefore, our data indicate a role of
Erm in regulating proliferation of glial cells.
Based on our data, activation of Erm in the peripheral
glial lineage is required for mitogenesis. Interestingly, the
mitogenic function of Erm appears to be specific for the
glial lineage since, although fewer neuronal clones were
generated upon EnR-Erm expression, these were not
smaller than in control cultures. It is not clear whether Erm
mediates the mitogenic activity of an extracellular signal in
the glial lineage or whether Erm is part of an intrinsic
program that ensures proliferation of neural crest cells
adopting a glial fate, independent of an external stimulus.
NRG1 type II (the NRG1 isoform also used in the present
study) regulates Erm expression in presumptive satellite
glia (Hagedorn et al., 2000) and might thus seem to repre-
sent a good candidate molecule to elicit Erm-dependent
mitogenesis. However, NRG1 type II does apparently not
increase the proliferation rate in cultured NCSCs (Shah et
al., 1994). Rather, it instructs NCSCs to adopt a satellite
glial fate in vitro (Hagedorn et al., 2000; Shah et al., 1994)
and plays a role in survival of at least a subset of multipo-
tent neural crest cells (Paratore et al., 2001). Intriguingly,
both glial fate and survival are not affected by loss of Erm
function. Furthermore, forced expression of dominant-
negative Erm also decreased the proliferation rate in glial
cells induced from neural crest cells upon Notch activation.
Hence, Erm regulates proliferation in a cell lineage-specific
manner independent of the stimulus that promoted the
generation of this lineage. This is also supported by our
finding that the regulation of glial cell cycle progression by
Erm is independent from the process of glial fate acquisi-
tion, since EnR-Erm not only impaired proliferation in
neural crest cells undergoing gliogenesis, but also in differ-
entiating glia that have already adopted their fate.
That Erm is involved in regulating proliferation is inter-
esting in light of the oncogenic potential attributed to
several Ets domain transcription factors (reviewed in Ditt-
mer and Nordheim, 1998). In particular, the Pea3 subfamily
members Erm, Pea3, and ER81 are upregulated in mam-
mary tumors overexpressing Neu/ErbB-2, a co-receptor of
NRG1. Recent experiments using dominant-negative Pea3
revealed that these Ets factors are required for the genera-
tion of Neu/ErbB-2-positive mammary tumors (Shepherd et
al., 2001). Likewise, activation of the Wnt/-catenin path-
way coincides with Erm and Pea3 upregulation in intestinal
and mammary tumors (Crawford et al., 2001; Howe et al.,
2001). Thereby, Pea3 factors might contribute to tumori-
genesis by activation of target genes involved in enhanced
invasiveness, suppression of apoptosis, and stimulation of
proliferation (Dittmer and Nordheim, 1998). Evidence for a
role of Ets factors in proliferation was provided by expres-
sion of dominant-negative mutants which suppressed mi-
togenic signaling by Colony Stimulating Factor-1 and Ras
(Langer et al., 1992; Wasylyk et al., 1994). Furthermore,
Ets-2 was shown to activate cdc2 and cyclin that are
implicated in regulating progression through the cell cycle
(Albanese et al., 1995; Wen et al., 1995). Finally, the Ets
factor Fli regulates Erythropoietin-induced proliferation of
erythroblasts, presumably by repressing transcription of the
retinoblastoma (Rb) gene (Pereira et al., 1999; Tamir et al.,
1999). Unlike Erm, which we showed to control prolifera-
tion without affecting survival or differentiation of glial
cells, the capacity of Fli to induce proliferation was coupled
with inhibition of both cell death and erythroblast differen-
tiation. In sum, the combined data are consistent with a
model in which Erm regulates cell cycle progression in
normal development of specific cell lineages and in onco-
genic growth of particular tumor subclasses.
Functional Diversity of Erm in Neural Crest Cell
Lineages
Although neural lineages derived from NCSCs share Erm
expression as a common feature, our study indicates that
Erm does not display equivalent cellular functions in these
lineages. Rather, as mentioned above, Erm appears to be
differentially required in a lineage-specific manner and
plays a role in neuronal fate acquisition and glial prolifera-
tion. Moreover, the continuous expression of Erm in differ-
entiated neurons (Hagedorn et al., 2000) is consistent with
a function also at later stages of neuronal development that
might be comparable to the role of the related factor ER81
in the formation of sensory-motor circuitry (Arber et al.,
2000). The mechanisms by which Erm is able to acquire
this functional diversity remain to be elucidated, but com-
binatorial interactions with regulatory factors are likely
involved in modulating the biological activity of Erm (Li et
al., 2000; Sharrocks, 2001; Sommer, 2001). Such interac-
tions together with differential postranslational modifica-
tions allow Ets domain transcription factors to act as
downstream effectors of multiple signaling pathways and to
control transcription of diverse sets of target genes (Wasy-
lyk et al., 1998; Yordy and Muise-Helmericks, 2000). Ets-1
is able to interact with different leucine zipper-containing
bHLH factors and selectively activates target gene expres-
sion in a tissue-specific manner, dependent on the combi-
nation of interacting partner molecules (Tian et al., 1999).
In B cells, functional synergy between a tissue-restricted
and an ubiquitous bHLH protein is mediated by cooperation
with an intermediate Ets domain transcription factor (Dang
et al., 1998). Further functional diversity of Ets proteins is
achieved by tissue-specific expression of splice variants or
by expression of varying concentrations of the Ets factor
(DeKoter and Singh, 2000; Iwamoto et al., 2000). In particu-
lar, similar to Erm in neural lineages, the Ets factor Pu.1 is
differentially required for proliferation, specification, or
differentiation in distinct myeloid lineages (DeKoter et al.,
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1998). In the neural crest, functional diversity of a given
transcription factor is not without precedence, since we
have recently demonstrated that survival and glial fate
acquisition of NCSCs are regulated by an interplay of the
transcription factor Sox10 with combinatorial signaling by
the extracellular environment (Paratore et al., 2001). Simi-
larly, we propose that Erm activity elicits distinct biological
responses in neural crest cells dependent on the intracellu-
lar context of other regulatory molecules and the combina-
tion of extracellular signals acting on the cells.
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